Impax Asset Management Group’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-176,426
Closed -$66.6M 286
2026
Q1
$66.6M Sell
176,426
-67,816
-28% -$29M 0.46% 55
2025
Q4
$105M Sell
244,242
-8,940
-4% -$3.89M 0.65% 50
2025
Q3
$113M Sell
253,182
-14,407
-5% -$6.52M 0.66% 50
2025
Q2
$130M Sell
267,589
-33,991
-11% -$19.4M 0.75% 44
2025
Q1
$186M Sell
301,580
-30,877
-9% -$17.6M 1.12% 28
2024
Q4
$176M Sell
332,457
-300
-0.1% -$169K 0.8% 44
2024
Q3
$200M Buy
332,757
+14,814
+5% +$8.4M 0.79% 45
2024
Q2
$173M Buy
317,943
+51,974
+20% +$29.8M 0.7% 53
2024
Q1
$171M Buy
265,969
+6,977
+3% +$4.24M 0.65% 53
2023
Q4
$151M Sell
258,992
-52,199
-17% -$29.2M 0.61% 59
2023
Q3
$162M Buy
311,191
+12,608
+4% +$6.55M 0.72% 49
2023
Q2
$162M Buy
298,583
+28,185
+10% +$15.4M 0.65% 59
2023
Q1
$145M Buy
+270,398
New +$138M 0.61% 58

Other funds holding CHE

Impax Asset Management Group's CHE Position: Q2 2026 in Review

Impax Asset Management Group sold out of Chemed (CHE) in Q2 2026, closing a stake of 176,426 shares — an estimated $66.6M sold.

Impax Asset Management Group first reported a position in CHE in Q1 2023 and held it in 13 quarters. The position peaked at $200M in Q3 2024. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Impax Asset Management Group reported no remaining Chemed position as of Q2 2026 after selling out during the quarter.
  • Impax Asset Management Group sold 176,426 Chemed shares in Q2 2026, an estimated $66.6M.
  • Impax Asset Management Group first reported a position in Chemed in Q1 2023 and held it in 13 quarters.
  • Impax Asset Management Group's Chemed position peaked at $200M in Q3 2024.
  • 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Impax Asset Management Group's 13F filing for Q2 2026, filed 11 Aug 2026.